Dermatology Life Quality Index in Patients with Psoriasis Treated with Biologic Versus Non-biologic Treatment in Malaysia: A Retrospective Cross-Sectional Study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource, 1 online resource.
- Language
-
Englisch
- Bibliographic citation
-
Dermatology Life Quality Index in Patients with Psoriasis Treated with Biologic Versus Non-biologic Treatment in Malaysia: A Retrospective Cross-Sectional Study ; volume:10 ; number:2 ; day:25 ; month:2 ; year:2023 ; pages:291-298 ; date:6.2023
Drugs - real world outcomes ; 10, Heft 2 (25.2.2023), 291-298, 6.2023
- Creator
-
Robinson, Suganthy
Moon, Tang Min
Eng, Tey Kwee
Yuen, Teoh Tze
Jong, Tang Jyh
Selvarajah, Latha
Chiang, Tan Wooi
Chiat, Teh Yeon
Tiong, John
Chinthapatla, Harini
Eng, Shu Kee
Thevarajah, Suganthi
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s40801-023-00359-1
- URN
-
urn:nbn:de:101:1-2023091208531172824403
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:51 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Robinson, Suganthy
- Moon, Tang Min
- Eng, Tey Kwee
- Yuen, Teoh Tze
- Jong, Tang Jyh
- Selvarajah, Latha
- Chiang, Tan Wooi
- Chiat, Teh Yeon
- Tiong, John
- Chinthapatla, Harini
- Eng, Shu Kee
- Thevarajah, Suganthi
- SpringerLink (Online service)
Other Objects (12)
Risk of Cutaneous T Cell Lymphoma with Psoriasis Biologic Therapies
Biologic system evaluation with ultrasound
Apremilast Prolongs the Time to First Biologic Therapy in Japanese Patients with Psoriasis
Treatment of Atopic Dermatitis with Biologic Drugs
Psoriasis, Vitiligo, and Biologic Therapy: Case Report and Narrative Review
Biologic monotherapy in the biologic naïve patient with rheumatoid arthritis (RA): results from an observational study
Biologic basis of pigmentation
Biologic and Small-Molecule Therapies for Moderate-to-Severe Psoriasis: Focus on Psoriasis Comorbidities
The Patient’s Guide to Psoriasis Treatment. Part 3: Biologic Injectables
Patients’ perspectives towards biologic dose reduction in psoriasis: a qualitative study
Itolizumab – A New Biologic for Management of Psoriasis and Psoriatic Arthritis
Biologic Therapy for Moderate to Severe Psoriasis. Real-World Follow-up of Patients Who Initiated Biologic Therapy at Least 10 Years Ago
Risk of Cutaneous T Cell Lymphoma with Psoriasis Biologic Therapies
Biologic system evaluation with ultrasound
Apremilast Prolongs the Time to First Biologic Therapy in Japanese Patients with Psoriasis
Treatment of Atopic Dermatitis with Biologic Drugs
Psoriasis, Vitiligo, and Biologic Therapy: Case Report and Narrative Review
Biologic monotherapy in the biologic naïve patient with rheumatoid arthritis (RA): results from an observational study
Biologic basis of pigmentation
Biologic and Small-Molecule Therapies for Moderate-to-Severe Psoriasis: Focus on Psoriasis Comorbidities
The Patient’s Guide to Psoriasis Treatment. Part 3: Biologic Injectables
Patients’ perspectives towards biologic dose reduction in psoriasis: a qualitative study
Itolizumab – A New Biologic for Management of Psoriasis and Psoriatic Arthritis
Biologic Therapy for Moderate to Severe Psoriasis. Real-World Follow-up of Patients Who Initiated Biologic Therapy at Least 10 Years Ago
Risk of Cutaneous T Cell Lymphoma with Psoriasis Biologic Therapies
Biologic system evaluation with ultrasound
Apremilast Prolongs the Time to First Biologic Therapy in Japanese Patients with Psoriasis
Treatment of Atopic Dermatitis with Biologic Drugs
Psoriasis, Vitiligo, and Biologic Therapy: Case Report and Narrative Review
Biologic monotherapy in the biologic naïve patient with rheumatoid arthritis (RA): results from an observational study
Biologic basis of pigmentation
Biologic and Small-Molecule Therapies for Moderate-to-Severe Psoriasis: Focus on Psoriasis Comorbidities
The Patient’s Guide to Psoriasis Treatment. Part 3: Biologic Injectables
Patients’ perspectives towards biologic dose reduction in psoriasis: a qualitative study
Itolizumab – A New Biologic for Management of Psoriasis and Psoriatic Arthritis